Te­va ex­ecs claim mixed win­ning streak in pricey opi­oids court bat­tle — as per­ma­nent peace re­mains elu­sive

Te­va ex­ecs turned up for the Q4 call with an­a­lysts to go deep in­to the num­bers, but it wasn’t long be­fore the lit­i­ga­tion around opi­oids took cen­ter stage in the Q&A.

CEO Kåre Schultz ad­dressed the re­cent court de­ci­sions in the US re­lat­ed to the phar­ma’s role in the US opi­oid epi­dem­ic — and how there have been mixed re­sults in dif­fer­ent courts, specif­i­cal­ly Cal­i­for­nia, Ok­la­homa and in New York.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER